Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0826-2022Class II

CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179

Diagnos Inc / initiated 2022-01-11 / Terminated / root cause: software

Diagnos Inc began a recall of CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179 on . FDA classified it as Class II and gives the reason as "Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0826-2022
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Diagnos Inc
Product
CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179
Product code
NFJ System, Image Management, Ophthalmic
Reason for recall
Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.
Root cause tag
software
FDA root cause
No Marketing Application
Action
On 01/11/22, a recall notice was emailed to the firm's customer who was informed to immediately cease using the affected software. The only version of software cleared for commercialization is CARA v1.2.1. The customer was asked to contact a quality management representative if they had questions or comments at 1-405-678-8882 ext. 235 or [email protected]
Quantity in commerce
1
Distribution
US: CA
Product codes and lots
Software Version 4.7.2

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0826-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0826-2022Class IITerminatedVoluntary: Firm initiated